A detailed history of Mackenzie Financial Corp transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 8,256 shares of DNLI stock, worth $202,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,256
Holding current value
$202,189
% of portfolio
0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$20.96 - $31.05 $173,045 - $256,348
8,256 New
8,256 $240,000
Q1 2024

May 10, 2024

BUY
$15.83 - $23.35 $167,164 - $246,576
10,560 New
10,560 $216,000
Q2 2023

Aug 03, 2023

BUY
$23.37 - $32.96 $244,567 - $344,926
10,465 New
10,465 $308,000
Q4 2022

Feb 14, 2023

BUY
$26.28 - $33.92 $37,790 - $48,776
1,438 Added 22.05%
7,959 $221,000
Q3 2022

Oct 07, 2022

SELL
$25.97 - $38.53 $9,790 - $14,525
-377 Reduced 5.47%
6,521 $200,000
Q2 2022

Aug 10, 2022

BUY
$20.88 - $35.19 $144,030 - $242,740
6,898 New
6,898 $203,000
Q1 2022

May 13, 2022

SELL
$29.0 - $47.27 $212,599 - $346,536
-7,331 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$42.59 - $55.02 $6,090 - $7,867
-143 Reduced 1.91%
7,331 $327,000
Q3 2021

Nov 08, 2021

BUY
$48.48 - $78.23 $172,055 - $277,638
3,549 Added 90.42%
7,474 $377,000
Q2 2021

Aug 11, 2021

BUY
$50.3 - $78.44 $197,427 - $307,877
3,925 New
3,925 $308,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.29B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.